NCI-H209

NCI-H209

收藏
  • 询价
  • 2025年08月17日
    avatar
    14金牌会员
  • 企业认证

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 询价记录
    • 技术资料
    • 器官来源

    • 库存

      大量

    • 运输方式

      冻存运输

    • 物种来源

    • 是否是肿瘤细胞

      1

    • 生长状态

      悬浮生长

    • 相关疾病

      小细胞肺癌

    • ATCC Number

      HTB-172™

    • 细胞形态

      上皮样

    Designations: NCI-H209 [H209]
    Depositors:  AF Gazdar, JD Minna
    Biosafety Level: 1
    Shipped: frozen
    Medium & Serum: See Propagation
    Growth Properties: aggregates in suspension
    Organism: Homo sapiens
    Morphology: epithelial

    Source: Organ: lung
    Disease: carcinoma; small cell lung cancer
    Derived from metastatic site: bone marrow
    Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
    Tumorigenic: Yes
    Oncogene: pRB + (abnormal, RB1)
    DNA Profile (STR): Amelogenin: X,Y
    CSF1PO: 11
    D13S317: 11
    D16S539: 9,12
    D5S818: 12
    D7S820: 9
    THO1: 7,9
    TPOX: 8
    vWA: 18,19
    Cytogenetic Analysis: This is a hyperdiploid human cell line., The modal chromosome number is 49, occurring at 28% with a frequency of higher ploidies of 1.3%. Ten to eleven markers were common to all cells including: der(1)t(1;3)(p22;p21), del(6)(q21), t(8q18q), del(12)(q13), der(14)t(14;?)(q32;?)., All had a single copy per cell. About 6 other markers were found, but they occurred only once in all metaphases karyotyped. Neither HSR nor DM were detected., Structurally normal B group chromosomes were not detected. All C group chromosomes were paired. A single copy of both the X and Y was found in all cells.
    Isoenzymes: AK-1, 1
    ES-D, 1
    G6PD, B
    Me-2, 0
    PGM1, 1-2
    PGM3, 1
    Gender: male
    Ethnicity: Caucasian
    Comments: The NCI-H209 cell line was derived by A.F. Gazdar and associates in 1979 from the bone marrow of a patient with small cell cancer of the lung.
    The bone marrow specimen was taken prior to therapy.
    The line is a classic SCLC cell line which expresses elevated levels of four biochemical markers (neuron specific enolase, brain isoenzyme of creatine kinase, L-DOPA decarboxylase and bombesin-like immunoreactivity.
    C-myc DNA sequences are not amplified.
    No gross structural DNA abnormalities were detected.
    The line produces normal amounts of p53 mRNA relative to normal lung.
    This is a cell line that grows as large aggregates in suspension. Only the aggregates are viable, but no meaningful viability percentage can be measured. The medium will normally contain large amounts of cell debris.
    The cells express an aberrant form of RB1 that is not phosphorylated, apparently due to a single point mutation at codon 706 (Cys -> Phe).
    Propagation: ATCC complete growth medium: Iscove's modified Dulbecco's medium, 90%; fetal bovine serum, 10% - OR - RPMI 1640 medium, 90%; fetal bovine serum, 10%
    Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended
    Medium Renewal: 2 to 3 times per week
    The line should be subcultured by dilution with fresh medium. Alternatively, the clusters may be collected by centrifugation and resuspended in fresh medium.
    Preservation: Culture medium, 95%; DMSO, 5%
    Related Products: normal (or near-normal) cell line established from the same patient:ATCC CRL-5948
    References: 1805: Little CD, et al. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194-196, 1983. PubMed: 6646201
    1806: Takahashi T, et al. p53: A frequent target for genetic abnormalities in lung cancer. Science 246: 491-494, 1989. PubMed: 2554494
    23056: Carney DN, et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res. 45: 2913-2923, 1985. PubMed: 2985257
    23080: Hensel CH, et al. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 50: 3067-3072, 1990. PubMed: 2159370
    23320: Kaye FJ, et al. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87: 6922-6926, 1990. PubMed: 2168563
    32276: Cairns P, et al. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions. Cancer Res. 57: 5356-5359, 1997. PubMed: 9393760
    32287: Rostomily RC, et al. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors. Cancer Res. 57: 3526-3531, 1997. PubMed: 9270024

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    • 作者
    • 内容
    • 询问日期
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1320
    博辉生物科技(广州)有限公司
    2025年10月28日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥600
    上海信裕生物科技有限公司
    2025年07月13日询价
    ¥680
    上海联迈生物工程有限公司
    2025年09月25日询价
    ¥1800
    上海酶研生物科技有限公司
    2025年07月12日询价
    NCI-H209
    询价